Trial Profile
Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2019
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 03 Feb 2017 Planned End Date changed from 1 Sep 2014 to 1 Aug 2017.
- 03 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium